| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $2.6B | $1.8B | $1.5B | $1.7B | $1.6B | — |
| Cost of Revenue | $1.0B | $0.8B | $1.5B | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | $0.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.5B | $0.4B | $0.3B | $0.3B | $0.3B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $4.39 | $3.92 | $4.09 | $3.85 | $3.70 | $0.97 | $0.85 | $0.90 |
| EPS (Diluted) | $4.37 | $3.91 | $4.08 | $3.85 | $3.68 | $0.96 | $0.84 | $0.89 |
| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.9B | $8.4B | $7.8B | $8.4B | $6.0B | $5.7B | $5.5B | $5.2B |
| Current Assets | $0.9B | $0.9B | $1.2B | $2.2B | $0.5B | $0.5B | $0.5B | $0.6B |
| Cash & Equivalents | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.5B | $1.5B | $1.2B | $1.0B | $0.8B | $0.9B | $0.7B | $0.7B |
| Stockholders' Equity | $3.4B | $3.1B | $2.6B | $2.3B | $2.2B | $2.1B | $2.0B | $2.0B |
| Metric | FY 2025↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.4B | $1.6B | $-1.5B | $0.4B | $0.3B | $0.5B | $0.3B |
| Investing Cash Flow | $-0.7B | $-0.7B | $-0.6B | $-0.5B | $-0.5B | $-0.4B | $-0.4B | $-0.4B |
| Capital Expenditures | $0.7B | $0.7B | $0.6B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B |
| Financing Cash Flow | $0.1B | $0.4B | $-0.9B | $2.0B | $0.1B | $0.1B | $-0.1B | $0.1B |